However, the finding that 10 of 25 cases with clinical annotation were recurrent tumours indicates that ASTRO PNC might represent progression of IDH-mutant astrocytomas towards a more malignant phenotype, similar to IDH-mutant oligodendrogliomas progressing to oligosarcomas [16]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).